Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company